EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-Selective Polydopamine Coating on Drug Nanoparticles

Danna Niezni, Dana Meron Azagury, Maytal Avrashami, Orr Bar-Natan iD, Yosi Shamay iD

ACS Applied Materials & Interfaces · 04.02.2026 · 18 (4) · 6452-6463

DOI: 10.1021/acsami.5c19920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 26.01.2026. Verfasst von Danna Niezni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering Technion - Israel Institute of Technology, Haifa, 32000, Israel. Hauptthemen laut MEDLINE: Indoles, Polymers, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Israel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polydopamine (PDA) is widely regarded as a universal coating material with substrate-independent adhesion. Here we report the first demonstration of selective PDA coating on small molecule drugs, revealing unexpected structure-dependent behavior that challenges this paradigm. Systematic screening of 30 chemotherapeutic agents in IR783-stabilized nanoparticles (>90% drug loading) showed dramatic coating variations governed by molecular structure rather than conventional hydrophobic or π-π interactions. Using Dragon molecular descriptors and principal component analysis, we developed a predictive decision tree model based on nitrogen content and bonding topology that correctly classified 80% of validation compounds. Coating selectivity correlates primarily with nitrogen percentage and N-C-N motifs, fundamentally expanding the understanding of PDA surface chemistry beyond nonselective adhesion mechanisms. Representative drugs (trametinib, dasatinib) demonstrated that PDA coating significantly improves colloidal stability and reduces aggregation without compromising drug loading or release kinetics. In vivo evaluation in HCT116 xenografts confirmed superior efficacy over free drug with improved formulation stability. These findings establish PDA coating selectivity as a previously unrecognized material phenomenon and provide computational tools for rational nanoparticle surface design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesPolymersNanoparticlesAntineoplastic AgentsDrug CarriersHumansAnimalsMiceHCT116 CellsDasatinib

Stichwörter der Autor:innen

decision treedrug deliverynanomedicinenanoparticlesnanoprecipitationpolydopamine

Substanzen

polydopamineIndolesPolymersAntineoplastic AgentsDrug CarriersDasatinib

Autor:innen und Institutionen

  • Department of Biomedical Engineering Technion - Israel Institute of Technology, Haifa, 32000, Israel.
  • The Norman Seiden Multidisciplinary Program for Nanoscience and Nanotechnology, Technion - Israel Institute of Technology, Haifa, 32000, Israel.

ORCID-Profile: Orr Bar-Natan, Yosi Shamay

Förderung

  • Ministry of Science and Technology, Israel

Zitieren

APA

Niezni, D., Azagury, D. M., Avrashami, M., Bar-Natan, O., & Shamay, Y. (2026). Structure-Selective Polydopamine Coating on Drug Nanoparticles. ACS Applied Materials & Interfaces, 18(4), 6452-6463. https://doi.org/10.1021/acsami.5c19920

Vancouver

Niezni D, Azagury DM, Avrashami M, Bar-Natan O, Shamay Y. Structure-Selective Polydopamine Coating on Drug Nanoparticles. ACS Applied Materials & Interfaces. 2026;18(4):6452-6463. doi:10.1021/acsami.5c19920

BibTeX
@article{Niezni2026,
  author = {Niezni, Danna and Azagury, Dana Meron and Avrashami, Maytal and Bar-Natan, Orr and Shamay, Yosi},
  title = {Structure-Selective Polydopamine Coating on Drug Nanoparticles},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {6452--6463},
  doi = {10.1021/acsami.5c19920}
}
Kostenlos starten →